Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional triamcinolone is the most effective treatment for alopecia areata, followed by excimer light therapy, and then topical minoxidil. The scalp responds better to treatment than the beard area.

Certain gene variations might increase the risk of a hair loss condition in Koreans.

Many treatments for alopecia areata have inconsistent results; for under 10s, use minoxidil with a corticosteroid, and for over 10s, add ILC and consider diphenylcyclopropenone for widespread cases.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Alopecia areata greatly affects people's life quality, mental health, and work life.

New treatments like JAK inhibitors show promise for reversing alopecia areata.

Botulinum A toxin injections reduced pain and promoted hair regrowth in a woman with a rare form of alopecia areata.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

A woman's hair loss was misdiagnosed as alopecia areata but was actually lichen planopilaris, needing immediate and ongoing treatment.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

A woman's hair loss was initially misdiagnosed as scarring hair loss but was actually a treatable autoimmune hair loss.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Sudden, unusual hair loss may indicate serious underlying health issues.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Alopecia Areata affects people of all ages worldwide, is likely caused by genetic and environmental factors, and can lead to stress and depression, highlighting the need for treatments that address both physical and mental health.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

Alopecia Areata (AA) causes significant emotional distress, including feelings of embarrassment, depression, and anxiety, and impacts social interactions and daily activities.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Early high-dose steroid treatment helps prolong disease-free periods in severe alopecia areata.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

Oral cyclosporine is more effective and safer than betamethasone for treating alopecia areata.

Alopecia areata can be managed with various treatments, and severe cases should be referred to dermatologists.

Corticosteroid pulse therapy is more effective for severe alopecia areata than combination therapy.

88% phenol is effective for treating alopecia areata.

Activated and non-activated PRP are equally safe and effective for treating alopecia areata.

Betamethasone is more effective for hair regrowth than latanoprost but has more side effects.

Diphenylcyclopropenone (DPCP) effectively treated both alopecia areata and verruca vulgaris.